ClinConnect ClinConnect Logo
Search / Trial NCT05814237

POS-ARI-ER Observational Study of Acute Respiratory Infections

Launched by EUROPEAN CLINICAL RESEARCH ALLIANCE FOR INFECTIOUS DISEASES (ECRAID) · Apr 13, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Infections Communicable Diseases

ClinConnect Summary

The POS-ARI-ER study is looking at how acute respiratory infections (ARI), like colds and flu, are diagnosed and treated in hospitals across Europe. These infections are a common reason for people to visit the hospital, and they can be caused by different viruses, like influenza and coronaviruses. The study aims to gather information on how doctors approach these infections, what treatments they use, and how well patients recover. By doing this, the researchers hope to better understand the characteristics of adult patients with ARI and the causes of their infections.

To be eligible for this study, participants need to be at least 18 years old and have symptoms of a new ARI that started in the last 10 days. They must be visiting an emergency room or a secondary care hospital and provide consent to take part. However, if someone has been in the hospital for more than two days or has already participated in this study, they cannot join. Participants can expect to help researchers learn more about ARI, which could lead to better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Clinical suspicion of a new episode of acute respiratory tract infection, with onset in the last 10 days
  • Patient presents to an emergency room or secondary care setting
  • Informed consent is provided by patient or their legal representative
  • Exclusion Criteria:
  • Patient has been transferred from another hospital
  • Patient admitted to hospital for \>2 days at the time of enrolment
  • Patient has been previously enrolled in the POS-ARI-ER study

About European Clinical Research Alliance For Infectious Diseases (Ecraid)

The European Clinical Research Alliance for Infectious Diseases (ECRAID) is a collaborative initiative dedicated to advancing clinical research in the field of infectious diseases across Europe. ECRAID aims to enhance the efficiency and effectiveness of clinical trials by fostering partnerships among academic institutions, healthcare providers, and industry stakeholders. Through a robust network and innovative methodologies, ECRAID seeks to facilitate the rapid development and implementation of clinical studies that address critical public health challenges posed by infectious diseases. By prioritizing patient-centric approaches and data-sharing practices, ECRAID is committed to improving health outcomes and informing policy decisions in the realm of infectious disease management.

Locations

Alicante, , Spain

Nijmegen, , Netherlands

Brussels, , Belgium

Lyon, , France

Sevilla, , Spain

Limoges, , France

Bari, , Italy

Grenoble, , France

Tours, , France

Alkmaar, , Netherlands

Patras, , Greece

Bucharest, , Romania

Cluj Napoca, , Romania

Gateshead, , United Kingdom

Liverpool, , United Kingdom

Craigavon, , United Kingdom

Zagreb, , Croatia

Bucharest, , Romania

Kragujevac, , Serbia

Edinburgh, , United Kingdom

London, , United Kingdom

Sheffield, , United Kingdom

Sunderland, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials